Dr. H. Kropshofer is Senior Personalized Healthcare Leader in the Pharmaceutical Division of F. Hoffmann-La Roche. He is located in the head quarter in Basel, Switzerland. He is a corporate expert in clinical immunology and immunosafety in late stage clinical drug development – with a particular focus on risk assessment and mitigation related to immunogenicity, hypersensitivity and infusion related side-effects of therapeutic proteins in the therapeutic areas oncology, hematology, inflammation, autoimmunity and neurological diseases.
Dr. Kropshofer is biochemist and immunologist by training. Prior to joining Roche in 2001, he was Research Group Leader at the German Cancer Research Center in Heidelberg, Germany and at the Basel Institute for Immunology, Switzerland. He is Associate Professor in cell biology & immunology at the University of Heidelberg since 2000.
Dr. Kropshofer has more than sixty publications to his credit in peer-reviewed journals, and is a regularly featured speaker at international conferences in Europe and USA.